|
WO0002903A1
|
|
Cs-1 peptidomimetics, compositions and methods of using the same
|
|
AU7717598A
|
|
Control of immune responses by modulating activity of glycosyltransferase
|
|
AU7277798A
|
|
Use of sialyl galactosides and related compounds as anti-angiogenic agents
|
|
WO9842656A1
|
|
Novel compounds
|
|
IL130964D0
|
|
Practical in vitro sialylation of recombinant glycoproteins
|
|
AU5252498A
|
|
Improved expression vectors
|
|
US6033667A
|
|
Method for detecting the presence of P-selectin
|
|
WO9737683A1
|
|
Nucleic acids encoding gdp-fucose pyrophosphorylase
|
|
WO9737682A1
|
|
Nucleic acids encoding gdp-fucose pyrophosphorylase
|
|
WO9734617A1
|
|
Hla binding peptides and their uses
|
|
WO9714707A1
|
|
SIALYL Lex ANALOGUES AS INHIBITORS OF CELLULAR ADHESION
|
|
US5854218A
|
|
Sialyl Lex analogues as inhibitors of cellular adhesion
|
|
WO9640942A1
|
|
Humanized antibodies to e-selectin
|
|
WO9640213A1
|
|
Manufacture and purification of peptides
|
|
US5922577A
|
|
Enzymatic synthesis of glycosidic linkages
|
|
CA2218120A1
|
|
Improved enzymatic synthesis of oligosaccharides
|
|
US5856159A
|
|
Production of galactosyltransferase
|
|
WO9603140A1
|
|
HLA binding peptides and their uses
|
|
US5811391A
|
|
Cyclic CS-1 peptidomimetics, compositions and methods of using same
|
|
US5811404A
|
|
Sialyl Lex analogues as inhibitors of cellular adhesion
|
